(2R,3S)-2-amino-4-(methylsulfanyl)butane-1,3-diol | 1010824-03-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (2R,3S)-2-amino-4-(methylsulfanyl)butane-1,3-diol
• 英文别名: (2R,3S)-2-amino-4-(methylthio)butane-1,3-diol；(2R,3S)-2-amino-4-methylsulfanylbutane-1,3-diol
• CAS: 1010824-03-9
• 化学式: C₅H₁₃NO₂S
• 分子量: 151.23
• InChiKey: KKBBWCQSDLWOBJ-RFZPGFLSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.3
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  91.8
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (2R,3S)-2-amino-4-(methylsulfanyl)butane-1,3-diol 在 lithium aluminium tetrahydride 、 氨 、 sodium cyanoborohydride 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 49.5h， 生成 (2R,3S)-2-(((4-amino-5-(benzyloxymethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)(methyl)amino)-4-(methylthio)butane-1,3-diol
  参考文献：
  名称：

  WO2008/30118

  摘要：

  公开号：
• 作为产物：
  描述：

  (4R,5S)-4-(hydroxymethyl)-5-[(methylsulfanyl)methyl]-1,3-oxazolidin-2-one 在 silica gel 作用下， 以 异丙醇 、 氢氧化钾 为溶剂， 反应 4.0h， 以to give (2R,3S)-2-amino-4-(methylthio)butane-1,3-diol (0.932 g, 94%) as a yellow solid的产率得到(2R,3S)-2-amino-4-(methylsulfanyl)butane-1,3-diol
  参考文献：
  名称：

  ACYCLIC AMINE INHIBITORS OF 5-METHYTIOADENOSINE PHOSPHORYLASE AND NUCLEOSIDASE

  摘要：

  本发明涉及一般公式（I）的化合物，它们是5'-甲基硫腺苷磷酸化酶或5'-甲基硫腺苷核苷酸酶的抑制剂。本发明还涉及使用这些化合物治疗希望抑制5'-甲基硫腺苷磷酸化酶或5'-甲基硫腺苷核苷酶的疾病或病况，包括癌症，并且涉及含有这些化合物的药物组合物。

  公开号：

  US20110046167A1

文献信息

• Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
  申请人：Clinch Keith

  公开号：US08383636B2

  公开（公告）日：2013-02-26

  The present invention relates to compounds of the general formula (I) which are inhibitors of 5′-methylthioadenosine phosphorylase or 5′-methylthioadenosine nucleosidase. The invention also relates to the use of these compounds in the treatment of diseases or conditions in which it is desirable to inhibit 5′-methylthioadenosine phosphorylase or 5′-methylthioadenosine nucleosidase including cancer, and to pharmaceutical compositions containing the compounds.

  本发明涉及通式（I）的化合物，其为5'-甲基硫腺苷磷酸酶或5'-甲基硫腺苷核苷酸酶的抑制剂。本发明还涉及这些化合物在治疗需要抑制5'-甲基硫腺苷磷酸酶或5'-甲基硫腺苷核苷酸酶的疾病或病况，包括癌症方面的应用，以及含有这些化合物的制药组合物。
• Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics
  作者：Keith Clinch、Gary B. Evans、Richard F.G. Fröhlich、Shivali A. Gulab、Jemy A. Gutierrez、Jennifer M. Mason、Vern L. Schramm、Peter C. Tyler、Anthony D. Woolhouse

  DOI：10.1016/j.bmc.2012.07.006

  日期：2012.9

  Several acyclic hydroxy-methylthio-amines with 3-5 carbon atoms were prepared and coupled via a methylene link to 9-deazaadenine. The products were tested for inhibition against human MTAP and Escherichia coli and Neisseria meningitidis MTANs and gave K-i values as low as 0.23 nM. These results were compared to those obtained with 1st and 2nd generation inhibitors (1S)-1-(9-deazaadenin-9-yl)-1,4-dideoxy-1,4-imino-5-methylthio-D-ribitol (MT-Immucillin-A, 3) and (3R,4S)-1-[9-deazaadenin-9-yl)methyl]3-hydroxy-4-methylthiomethylpyrrolidine (MT-DADMe-Immucillin-A, 4). The best inhibitors were found to exhibit binding affinities of approximately 2- to 4-fold those of 3 but were significantly weaker than 4. Cleavage of the 2,3 carbon-carbon bond in MT-Immucillin-A (3) gave an acyclic product (79) with a 21,500 fold loss of activity against E. coli MTAN. In another case, N-methylation of a side chain secondary amine resulted in a 250-fold loss of activity against the same enzyme [(+/-)-65 vs (+/-)-68]. The inhibition results were also contrasted with those acyclic derivatives previously prepared as inhibitors for a related enzyme, purine nucleoside phosphorylase (PNP), where some inhibitors in the latter case were found to be more potent than their cyclic counterparts. (C) 2012 Elsevier Ltd. All rights reserved.
• WO2008/30118
  申请人：——

  公开号：——

  公开（公告）日：——
• ACYCLIC AMINE INHIBITORS OF 5-METHYTIOADENOSINE PHOSPHORYLASE AND NUCLEOSIDASE
  申请人：Clinch Keith

  公开号：US20110046167A1

  公开（公告）日：2011-02-24

  The present invention relates to compounds of the general formula (I) which are inhibitors of 5′-methylthioadenosine phosphorylase or 5′-methylthioadenosine nucleosidase. The invention also relates to the use of these compounds in the treatment of diseases or conditions in which it is desirable to inhibit 5′-methylthioadenosine phosphorylase or 5′-methylthioadenosine nucleosidase including cancer, and to pharmaceutical compositions containing the compounds.

  本发明涉及一般公式（I）的化合物，它们是5'-甲基硫腺苷磷酸化酶或5'-甲基硫腺苷核苷酸酶的抑制剂。本发明还涉及使用这些化合物治疗希望抑制5'-甲基硫腺苷磷酸化酶或5'-甲基硫腺苷核苷酶的疾病或病况，包括癌症，并且涉及含有这些化合物的药物组合物。